INVO BioScience, Inc. stock is up 48.57% since 30 days ago. The next earnings date is Apr 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 15 December’s closed higher than November.
INVO Bioscience, Inc. provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo. The company was founded in 2007 and is based in Sarasota, Florida.